The ASP, an international programme funded by the Amgen Foundation, provides hundreds of selected undergraduates with the opportunity to engage in a hands-on research experience at many of the world’s leading educational institutions.
(Reuters) - AstraZeneca and Amgen's experimental drug reduced asthma attacks in patients with severe and uncontrolled forms of the respiratory condition in a large study, showing promise for wider use against different triggers.
HYDERABAD (Reuters) - The rising adoption of artificial intelligence in the pharmaceutical industry dominated discussions at a conference in India this week, while executives largely preferred to wait for more clarity on U.S. President Donald Trump's tariff threats.
KUALA LUMPUR: AMMB Holdings Bhd is on track with its refreshed Winning Together (WT29) strategy and is optimistic about its prospects in the current financial year ending March 31, 2025 (FY25).
NEW YORK, Nov. 26 (Xinhua) -- The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose an average of up to 20 percent of their weight in a year.
Wall Street stocks, led by S&P 500 and the Nasdaq, ended higher on Tuesday, as technology stocks rebounded, while investors digested President-elect Donald Trump's tariff pledges on top trade partners and the latest minutes from the Federal Reserve.
KUALA LUMPUR: AMMB Holdings Bhd (AmBank) said it is optimistic over its prospects in FY25 now it has arrived at the halfway mark with an improved performance over the previous year.
Pfizer Inc has sold US$31bil (RM140bil) of debt in the fourth-largest US bond sale ever, according to a source.
WALL Street's main indexes were set to open higher on Friday after a softer-than-expected jobs report revived hopes of the Federal Reserve cutting interest rates this year, while gains in Apple and Amgen on upbeat corporate updates added support.
Obesity pill data released by Viking Therapeutics Inc and AstraZeneca Plc at a big conference foreshadowed an increasingly competitive landscape for weight-loss therapies, sending down shares of drugmakers in the field.
The Dow Jones Industrial Average and S&P 500 closed lower on Wednesday, pulling back from recent record highs driven by China's sweeping stimulus package, as investors awaited economic indicators and signals on upcoming interest rate cuts.
When drugmaker Amgen Inc sold US$24bil of bonds in February to fund its takeover of Horizon Therapeutics Plc, it had 12 banks as joint bookrunners and a further 16 as co-managers on the deal. Eight of the 16 were small investment banks certified as owned by women, minorities or military veterans.
DUBAI: A growing list of global companies are setting a price or charging themselves for each tonne of their carbon emissions, looking to shape their investments and business for future pollution taxes or other new climate rules.
LONDON (Reuters) - Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of people needed to test medicines, both accelerating drug development and potentially saving millions of dollars.
KUALA LUMPUR: AMMB Holdings Bhd (AmBank) remains optimistic over its prospects for its 2025 financial year (FY25) after having observed the positive economic momentum across all sectors in 2024.
AMMB Holdings Bhd (AmBank) remains optimistic about its prospects for its financial year 2025 (FY25) after having observed the positive economic momentum across all sectors in 2024.
RIVAL drugmakers AbbVie Inc, Amgen Inc and Takeda Pharmaceuticals Inc on Monday said they have begun treating patients in a trial to quickly show whether a drug from each company can be repurposed and used against COVID-19, the disease caused by the novel coronavirus.
Washington: The US Federal Trade Commission (FTC) has suspended its challenge of Amgen’s US$27.8bil purchase of Horizon Therapeutics, allowing the FTC to consider whether the agency should settle the case, a filing late last Friday shows.
WALL Street was set to open higher on Wednesday, aided by a dovish turn by Japan's top policymaker after a surprise interest rate hike last week partly sparked heavy volatility in global markets.
PETALING JAYA: AMMB Holdings Bhd (AmBank Group is maintaining a bullish outlook on its prospects, despite potential external challenges such as the volatility in the global growth trajectory and heightening geopolitical tensions